AzTrials
AzTrials

Tibial FracturesPOSITIFNCT03172715

Prosthesis Versus Osteosynthesis in Proximal Tibia Fractures

A study testing Locking plate and TKR in people with Tibial Fractures, run by Central Finland Hospital District at 8 sites in Finland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to compare knee function and pain one year after treatment of intra-articular proximal tibia fracture using either osteosynthesis with a locking plate (ORIF) or primary total knee replacement (TKR) in patients over 65 years of age. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Tibial Fractures
What is being tested?
Locking plate and TKR
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
8 sitesFinland
Study dates
9 Jan 2018to Jun 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Acute intra-articular proximal tibia fracture with impression of the joint cartilage (Schatzker grades II to VI)
  • Impression of tibial plateau min 2 mm
  • Intact patellar tendon
  • The patient accepts both treatment options (osteosynthesis and arthroplasty)

Who cannot join

  • Not voluntary
  • Previous arthroplasty of the knee
  • Previous fracture affecting the knee joint
  • Inability to co-operate
  • Not independent (institutionalized living before fracture)
  • Severe osteoarthritis (Kellgren-Lawrence grade 4)
Show all 17Show fewer
  • Open fracture (Gustilo grade 2 or over)
  • Progressive metastatic malign disease
  • Multiple fractures requiring operative treatment
  • Severe soft tissue injury around the knee (Tscherne classification grade 3)
  • Avulsion fracture of the patellar tendon or concomitant patellar tendon tear
  • Inability to walk before fracture
  • Severe medical comorbidities
  • Body Mass Index over 40
  • Unacceptably high risk of surgery due to severe medical comorbidities
  • Significant arterial or nerve trauma
  • Severe substance abuse

Trial locations and contacts

8 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Juha Paloneva, MD, PhD contact

+358 14 2693119

juha.paloneva@ksshp.fi

8 sites in 1 country

Finland8 sites, 8 recruiting
  • Central Finland Hospital

    Jyväskylä, 40620

    Juha Paloneva, MD, PhD, +358 14 2693119

    Valtteri Tapper, MD

    Recruiting
  • Kuopio University Hospital

    Kuopio

    Jussi Jalkanen, MD

    Jussi Jalkanen, MD, PhD

    Not yet recruiting
  • Päijät-Häme Central Hospital

    Lahti

    Jussi Haapala, MD, PhD

    Jussi Haapala, MD, PhD

    Not yet recruiting
  • Oulu University Hospital

    Oulu

    Tuukka Niinimäki, MD, PhD

    Tuukka Niinimäki, MD, PhD

    Not yet recruiting
  • Seinäjoki Central Hospital

    Seinäjoki

    Janne Jousmäki, MD, PhD

    Janne Jousmäki, MD, PhD

    Not yet recruiting
  • Coxa Joint Replacement Hospital

    Tampere

    Jyrki Nieminen, MD

    Jyrki Nieminen, MD, PhD

    Not yet recruiting
  • Tampere University Hospital

    Tampere

    Minna Laitinen, MD, PhD

    Ilari Pajamäki, MD

    Not yet recruiting
  • Turku University Hospital

    Turku

    Niko Strandberg, MD, PhD

    Niko Strandberg, MD, PhD

    Not yet recruiting

Other trials in Finland

About this study

Official title: Prosthesis Versus Osteosynthesis in Treatment of Intra-articular Fractures of Proximal Tibia: A Randomized, Controlled, Trial

The aim of this study is to compare knee function and pain one year after treatment of intra-articular proximal tibia fracture using either osteosynthesis with a locking plate (ORIF) or primary total knee replacement (TKR) in patients over 65 years of age.

Read the detailed description

Intra-articular proximal tibial fractures are relatively common in the elderly. They constitute 8% of all fractures in patients over 65 years. Open reduction and internal fixation (ORIF) is the golden standard treatment for these fractures.

The treatment with ORIF is associated with significant co-morbidity due to complicating concomitant factors, such as osteoporosis, poor co-operation, infection and inadequate stability of osteosynthesis. A high failure rate (30-79 %) of fixation of tibia plateau fractures in elderly people has been reported. Most of these fractures occur in elderly persons who are at risk to lose their ability to walk independently, because of partial immobilization is required initially and full weight bearing is not allowed during 6 to 8 weeks after the operation. The risk of post-traumatic osteoarthritis has been reported to be 5.3-times higher than in the normal population even if adequate stability is achieved and other conditions normalized for fracture healing. It has also been reported that total knee replacement (TKR) performed for post-traumatic arthritis after tibial plateau fracture lead to worse outcome compared with TKR due to primary osteoarthritis. In addition, previous operations increase the risk of complications after TKR. The complication rate in secondary TKR has been reported to be over 18 %.

The available data regarding TKR as a primary treatment option for proximal tibial plateau fracture suggest that fast mobilization and return to normal daily activities may be achieved. These data also suggest a low rate of complications. There are no randomized controlled trials comparing the outcomes of the traditional treatment option (open reduction- internal fixation, ORIF) and TKR as primary treatment of these fractures. In this study investigators compare the outcomes of locking plate osteosynthesis and total knee arthroplasty according to Oxford knee score, pain, ability to walk, or quality of life one year after randomization in 98 patients aged over 65 years.

Being tested
Locking plate, TKR
Keywords
Open reduction internal fixation, Arthroplasty, Surgery, Randomized controlled trial
Medical subject headings
Tibial Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Locking plateProcedure or surgery

    Osteosynthesis

  • TKRProcedure or surgery

    Total knee arthroplasty

Study groups in NCT03172715
Study groupRoleWhat they receive
ORIF (open reduction-internal fixation)Active comparatorOsteosynthesis with locking plate(s) will be performed using medial and/or lateral incision, according to morphology of the fracture. Additional osteosynthesis material will be used when necessary. The articular surface will be reduced and bone transplantation or bone substitute used if required. Postoperatively, touch-down weight bearing will be allowed for 6 weeks, followed by 2 weeks of half-weight-bearing period. A walker or wheelchair will be used when necessary.
Receives: Procedure: Locking plate
TKR (total knee replacement)ExperimentalArthroplasty of the knee will be performed within two weeks after the fracture. Medial parapatellar approach will be used. The minimal possible constraint of the prosthesis (cruciate retaining, posterior cruciate sacrificing or semi-constrained) will be used. A possible insufficient bone stock may be rebuilt with augments. Hinged prosthesis will be used only if stability of the medial collateral ligament is insufficient. A cemented or uncemented tibial stem extender (minimum length 50mm) will be used in all cases. Additional osteosynthesis will be used when necessary. Postoperatively, the patients will be allowed full weight bearing as tolerated.
Receives: Procedure: TKR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee function

    Oxford knee score 12 months after randomisation

    Measured: 12 months

Secondary outcomes (6)
  1. Change in knee function

    Change in Oxford knee score

    Measured: Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years

  2. Change in pain

    Numeric rating scale (rest, night, exercise)

    Measured: Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years

  3. Change in physical performance

    Short Physical Performance Battery (SPPB)

    Measured: 6 weeks (TKR only), 3 months, 6 months, 12 months, 24 months, 5 years, 10 years

  4. Change in quality of life

    Short form-36 (SF-36)

    Measured: Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years

  5. Reoperations

    Need for revision surgery

    Measured: Up to 10 years following randomisation

  6. Satisfaction

    Satisfaction with knee (Numeric rating scale, range 0 to 10)

    Measured: Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2017
  2. Study start9 Jan 2018
  3. Primary completionJun 2026 (estimated)
  4. Study completionJun 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
98 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03172715
Sponsor's protocol ID
Dnro 6U/2017
Acronym
POSITIF
Status last verified
Aug 2024
First submitted
22 May 2017
Last updated
22 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Houdek MT, Watts CD, Shannon SF, Wagner ER, Sems SA, Sierra RJ. Posttraumatic Total Knee Arthroplasty Continues to Have Worse Outcome Than Total Knee Arthroplasty for Osteoarthritis. J Arthroplasty. 2016 Jan;31(1):118-23. doi: 10.1016/j.arth.2015.07.022. Epub 2015 Jul 17.

    PubMed 26264176
  • Wasserstein D, Henry P, Paterson JM, Kreder HJ, Jenkinson R. Risk of total knee arthroplasty after operatively treated tibial plateau fracture: a matched-population-based cohort study. J Bone Joint Surg Am. 2014 Jan 15;96(2):144-50. doi: 10.2106/JBJS.L.01691.

    PubMed 24430414
  • Somersalo A, Paloneva J, Kautiainen H, Lonnroos E, Heinanen M, Kiviranta I. Incidence of fractures requiring inpatient care. Acta Orthop. 2014 Sep;85(5):525-30. doi: 10.3109/17453674.2014.908340. Epub 2014 Apr 3.

    PubMed 24694275
  • Malviya A, Reed MR, Partington PF. Acute primary total knee arthroplasty for peri-articular knee fractures in patients over 65 years of age. Injury. 2011 Nov;42(11):1368-71. doi: 10.1016/j.injury.2011.06.198. Epub 2011 Jul 18.

    PubMed 21763651
  • Kini SG, Sathappan SS. Role of navigated total knee arthroplasty for acute tibial fractures in the elderly. Arch Orthop Trauma Surg. 2013 Aug;133(8):1149-54. doi: 10.1007/s00402-013-1792-8. Epub 2013 Jun 16.

    PubMed 23771128
  • Shimizu T, Sawaguchi T, Sakagoshi D, Goshima K, Shigemoto K, Hatsuchi Y. Geriatric tibial plateau fractures: Clinical features and surgical outcomes. J Orthop Sci. 2016 Jan;21(1):68-73. doi: 10.1016/j.jos.2015.09.008. Epub 2015 Dec 6.

    PubMed 26671570
  • Haufe T, Forch S, Muller P, Plath J, Mayr E. The Role of a Primary Arthroplasty in the Treatment of Proximal Tibia Fractures in Orthogeriatric Patients. Biomed Res Int. 2016;2016:6047876. doi: 10.1155/2016/6047876. Epub 2016 Jan 18.

    PubMed 26885510

Questions about this trial

What is this clinical trial studying?

A study testing Locking plate and TKR in people with Tibial Fractures, run by Central Finland Hospital District at 8 sites in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Juha Paloneva, MD, PhD (+358 14 2693119, juha.paloneva@ksshp.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee function (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03172715, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in